Funding awarded to develop a global Pathogen Data Network
EMBL-EBI and colleagues from other 11 institutes commit to pathogen data sharing project.
2024
announcements
Using Data Hubs to analyse SARS-CoV-2 and other pathogen sequences
The SARS-CoV-2 Data Hubs are a set of tools coupled with infrastructure that support four components: the submission, analysis, presentation and visualisation of SARS-CoV-2 raw read data, and its resulting analyses. What makes Data Hubs attractive is a unique set of features: A new publication in…
2024
updates-from-data-resources
Extending the network of infectious disease data portals: developments in Sweden and The Netherlands
Two new data portals are set to support infectious disease monitoring and research across Europe; the Swedish Pathogens Data Portal and the Netherlands COVID-19 Data Portal.
2023
updates-from-data-resources
Pathogens Portal: The new gateway to public pathogen data
Enabling researchers worldwide to share and analyse pathogen data generated across the world
SCIENCE & TECHNOLOGY2023
sciencescience-technologytechnology-and-innovation
Welcome: John Lees
John Lees joins EMBL-EBI as a Group Leader in Pathogen informatics and modelling.
LAB MATTERSPEOPLE & PERSPECTIVES2022
lab-matterspeople-perspectives
Pathogen data sharing – key to pandemic preparedness
Researchers lay out a set of principles for open genomic data sharing or pathogens
SCIENCE & TECHNOLOGY2022
perspectivesscience-technology
A new era for European molecular biology
EMBL announces details about its next programme, ‘Molecules to Ecosystems’. It will guide studying life across scales and in context with changing environments.
EMBL ANNOUNCEMENTSLAB MATTERS2022
announcementsembl-announcementslab-matters
Sorting out HIV
An EMBL collaboration devises a new method that could speed up vaccine development for HIV
SCIENCE & TECHNOLOGY2017
sciencescience-technology
Structure of key system for TB infection
EMBL scientists add crucial knowledge to understanding of the bacterium that causes tuberculosis
SCIENCE & TECHNOLOGY2017
sciencescience-technology
Microbiomes: Our humble overlords
What's a microbiome? How on Earth do they work?
SCIENCE & TECHNOLOGY2016
sciencescience-technology
Pandemic! A public event
EMBL-EBI organises an evening of talks and discussion about the global spread of infectious disease.
2015
events
Awards & Honours
EMBL scientists regularly receive prestigious awards – meet the latest honourees.
LAB MATTERS2015
lab-matters
Fighting bacteria – with viruses
Molecular switch enables viruses to destroy C.diff bacteria – potential alternative to antibiotics
SCIENCE & TECHNOLOGY2014
sciencescience-technology
The future’s bright
Surprising protein from a flu-like virus is 10 000th ESRF structure
SCIENCE & TECHNOLOGY2014
sciencescience-technology
Nothing but blue skies
Focusing on basic research is crucial for the development of more advanced genetics techniques
SCIENCE & TECHNOLOGY2014
sciencescience-technology
HIV: hacking, immaturity and viruses
High-resolution structure reveals crucial interactions for HIV maturation
SCIENCE & TECHNOLOGY2014
sciencescience-technology
Tsetse fly genome sequenced
Tsetse fly genome sequenced; scientists hope to find new ways to control sleeping sickness.
SCIENCE & TECHNOLOGY2014
sciencescience-technology
Catching the cap-snatcher
Researchers at the European Molecular Biology Laboratory (EMBL) in Grenoble, France, have determined the detailed 3-dimensional structure of part of the flu virus’ RNA polymerase, an enzyme that is crucial for influenza virus replication. This important finding is published today in PLoS…
SCIENCE & TECHNOLOGY2012
sciencescience-technology
A stepwise retreat: how immune cells catch pathogens
To protect us from disease our immune system employs macrophages, cells that roam our body in search of disease-causing bacteria. With the help of long tentacle-like protrusions, macrophages can catch suspicious particles, pull them towards their cell bodies, internalise and destroy them. Using a…
SCIENCE & TECHNOLOGY2007
sciencescience-technology
New compound effectively treats fungal infections
A new mechanism to attack hard-to-treat fungal infections has been revealed by scientists from the biotech company Anacor Pharmaceuticals Inc., California, and the European Molecular Biology Laboratory [EMBL] outstation in Grenoble, France. In the current issue of Science they describe…
SCIENCE & TECHNOLOGY2007
sciencescience-technology
No results found